Fornix triamcinolone injection for thyroid orbitopathy
详细信息 查看全文
- 作者：Shirin Hamed-Azzam ; Abed Mukari…
- 关键词：Clinical activity score ; Thyroid orbitopathy ; Triamcinolone acetate ; Active thyroid orbitopathy
- 刊名：Graefe's Archive for Clinical and Experimental Ophthalmology
- 出版年：2015
- 出版时间：May 2015
- 年：2015
- 卷：253
- 期：5
- 页码：811-816
- 全文大小：354 KB
- 参考文献：1.Warwar RE (1990) New in-sights into pathogenesis and potential therapeutic options for Graves-orbitopathy. Curr Opin Ophthalmol 10:358-61View Article
2.Campbell JC (1989) Immunology of Graves-ophthalmopathy: retrobulbar histology and histochemistry. Acta Endocrinol 121:9-6View Article
3.Ohtsuka K, Hashimoto M (1999) H-magnetic resonance spectroscopy of retrobulbar tissue in Graves-ophthalmopathy. Am J Ophthalmol 128:715-19View Article PubMed
4.Kahaly G (1994) Immunohistochemical staining of retrobulbar adipose tissue in Graves-ophthalmopathy. Clin Immunol Immunopathol 73:53-2View Article PubMed
5.Mourits M, Koornneef L, Wiersinga W et al (1989) Clinical criteria for the assessment of disease activity in Graves-ophthalmopathy: a novel approach. Brit J Ophthalmol 74:639-44View Article
6.Bartalena L, Marcocci C, Bogazzi F et al (1991) Glucocorticoid therapy of Graves-ophthalmopathy. Exp Clin Endocrinol 97:320View Article PubMed
7.Bartalena L, Marcocci C, Pinchera A (1997) Treating severe Graves-ophthalmopathy. Baillieres Clin Endocrinol Metab 11:521-36View Article PubMed
8.Tagami T, Tanaka K, Sugawa H (1996) High-dose intravenous steroid pulse therapy in thyroid-associated ophthalmopathy. Endocr J 43:689-99View Article PubMed
9.Ohtsuka-Sato A, Kawaguchi S, Hashimoto M et al (2003) Effect of steroid pulse therapy with and without orbital radiotherapy on Graves-Ophthalmopathy. Am J Ophthalmol 135:285-90View Article
10.Gebertt S (1961) Depot-methylprednisolone for subconjunctival and retrobulbar injections. Lancet 2:344-45View Article PubMed
11.Ebner R, Devoto MH, Weil D et al (2004) Treatment of thyroid associated ophthalmopathy with periocular injections of triamcinolone. Br J Ophthalmol 88:1380-386View Article PubMed Central PubMed
12.Goldberg RA (2004) Orbital steroid injections. Br J Ophthalmol 88:1359-360View Article PubMed Central PubMed
13.Gupta OP, Boynton JR, Sabini P et al (2003) Proptosis after retrobulbar corticosteroid injections. Ophthalmology 110:443-47View Article PubMed
14.Smith JR, George RK, Rosenbaum JT (2002) Lower eyelid herniation of orbital fat may complicate periocular corticosteroid injection. Am J Ophthalmol 133:845-47View Article PubMed
15.Bordaberry M, Marques DL, Pereira-Lima JC et al (2009) Repeated peribulbar injections of triamcinolone acetonide: a successful and safe treatment for moderate to severe Graves-ophthalmopathy. Acta Ophthalmol 87:58-4View Article PubMed
16.Alkawas A, Hussein A, Shahien E (2010) Orbital steroid injection versus oral steroid therapy in management of thyroid-related ophthalmopathy. Clin Exp Ophthalmol 38:692-97View Article
17.Bartalena L, Baldeschi L, Dickinson A et al (2008) Consensus statement of the European Group on Graves-orbitopathy (EUGOGO) on management of GO. Eur J Endocrinol 158:273-85View Article PubMed
18.Lee S, Rim T, Jang S et al (2013) Treatment of upper eyelid retraction related to thyroid-assosciated ophthalmopathy using subconjunctival triamcinolone injections. Graefes Arch Exp Ophthlamol 251:261-70View Article
19.Xu D, Liu Y, Xu H et al (2012) Repeated triamcinolone acetonide injection in the treatment of upper-lid retraction in patients with thyroid-associated ophthalmopathy. Can J Ophthalmol 47:34-1View Article PubMed
20.Chee E, Chee S-P (2008) Subconjunctival injection of trimacinolone in the treatment of lid retraction of patients with thyroid eye disease: a case series. Eye 22:311-15View Article PubMed
21.Lee J, Lee H, Park M et al (2012) Subconjunctival injection of Triamcinolone for the treatment of upper lid retraction associated with thyroid eye disease. J Craniofac Surg 23:1755-758View Article PubMed - 作者单位：Shirin Hamed-Azzam (1)
Abed Mukari (1)
Ilan Feldman (1)
Walid Saliba (1)
Haneen Jabaly-Habib (1)
Daniel Briscoe (1)
1. Technion Faculty of Medicine, Haifa, Emek Medical Center, Erez 2 Nazareth Illit, 17820, Afula, Israel - 刊物类别：Medicine
- 刊物主题：Medicine & Public Health
Ophthalmology - 出版者：Springer Berlin / Heidelberg
- ISSN：1435-702X
文摘
Purpose In this pilot study we aimed to examine the association between eyelid fornices triamcinolone injections and clinical activity score in patients with active thyroid orbitopathy. Methods Adult patients aged 18?years or older, diagnosed with active thyroid orbitopathy and a clinical activity score ? were recruited to this interventional prospective pilot study between 2010 and 2013. Three upper and lower fornices injections of triamcinolone acetate 20?mg (40?mg/ml) were administered at 4-week intervals. Each patient included was followed up for a period of 6?months. Clinical activity score was estimated at each monthly visit. Extraocular muscle thickness was measured by ultrasound examination at entrance and at the last visit. Results Eleven eyes of seven patients were included in our study. Initial clinical activity score was 3.81?±-.80 and fell to 0.63?±-.72 during a 6-month follow-up. There was a significant difference in clinical activity score between the baseline examination and the following visits (p-value-lt;-.0001). Ultrasound examination showed a significant decrease in medial and lateral rectus muscle thickness following treatment; median difference ?.93 and ?.58, respectively (p-value-lt;-.005). Lid retraction was reduced by the treatment. Side effects included a transitory increase in intraocular pressure in one patient, which was controlled with topical medication. Conclusions In this pilot study a series of three separate triamcinolone fornix injections at 4-week intervals reduces the inflammatory effects of thyroid orbitopathy, as measured by clinical activity score. The treatment was simple, effective, and safe eliminating the side effects associated with systemic corticosteroid use.